Evidence map›Paper›PMID 23632416›Full record

ArticlePhysiological genomics2013

miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1.

Alicia M Evangelista, Anne M Deschamps, Delong Liu, Nalini Raghavachari, Elizabeth Murphy

Abstract read
In one paragraph

Article in Physiological genomics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Epigenetic regulation of sex dimorphism in cardiovascular health.Canadian journal of physiology and pharmacology · 2024
    Review
  2. miR-222 regulates cell growth, apoptosis, and autophagy of interstitial cells of Cajal isolated from slow transit constipation rats by targeting c-kit.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2021
    Article
  3. What microRNAs could tell us about the human X chromosome.Cellular and molecular life sciences : CMLS · 2020
    Review
  4. Review
  5. miRNA as a New Regulatory Mechanism of Estrogen Vascular Action.International journal of molecular sciences · 2018
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Characterization of the sex-dependent myocardial S-nitrosothiol proteome.American journal of physiology. Heart and circulatory physiology · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alicia M EvangelistaSystems Biology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Anne M Deschamps
Delong Liu
Nalini Raghavachari
Elizabeth Murphy
National Institutes of Health · USNational Heart Lung and Blood Institute · US

Funding

DNA Sequencing Core (DSC)ZICHL006058 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ZHU, JUN · 2010 to 2016
$16.6M
Mechanisms involved in male-female differences in cardioprotectionZIAHL002065 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MURPHY, ELIZABETH · 2009 to 2025
$6.5M
Mechanisms of cardiac ischemia-reperfusion injury and cardioprotectionZ01HL002066 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MURPHY, ELIZABETH · 2008 to 2008
$607k
Intramural NIH HHSNHLBI NIH HHS Z01HL-002066NHLBI NIH HHS Z01HL-006059
6 · The paper itself

Abstract

It is well recognized that there is sex-dimorphic expression of mRNA and protein in the heart; however, the underlying mechanism is poorly understood. Endothelial nitric oxide synthase (eNOS) is an important regulator of cardiac function, and the expression levels of eNOS differ between male and female hearts. The aim of this study was to examine whether expression of specific microRNA (miRNA, miR) in males and females contributes to changes in the expression of eNOS. miRNA was extracted from the myocardium of male and female C57BL/6 mice and subjected to an Affymetrix miRNA array. Decreased expression of miR-222 was discovered in females and confirmed by qRT-PCR from whole heart or isolated cardiomyocytes. The transcription factor V-ets erythroblastosis virus E26 oncogene homolog-1 (ets-1) was identified as a potential target of miR-222 using TargetScan, and fivefold increased ets-1 protein expression in females was confirmed by Western blot. Targeting of ets-1 by miR-222 was determined in HEK293 cells overexpressing luciferase under regulation of either the ets-1 3'-UTR, a null 3'-UTR control, or a scrambled ets-1 3'-UTR and treated with a small molecule miR-222 mimic or inhibitor. Additionally qRT-PCR confirmed that mRNA levels of the ets-1 transcriptional target, eNOS, were 25% higher in females. Compared with untreated myocyte controls, 50% inhibition of eNOS expression was achieved by treatment with a miR-222 mimic, compared with a 25% increase due to miR-222 inhibitor. Our findings indicate that sex-dependent miR-222 regulation alters the expression of the cardiac regulatory protein eNOS.

Indexed as

Sex CharacteristicsAnimalsFemaleGene Expression ProfilingGene Expression RegulationHEK293 CellsHumansMaleMiceMice, Inbred C57BLMicroRNAsMyocardiumMyocytes, CardiacNitric Oxide Synthase Type IIIProto-Oncogene Protein c-ets-1Ets1 protein, mouseMicroRNAsMIRN222 microRNA, mouseNitric Oxide Synthase Type IIINos3 protein, mouseProto-Oncogene Protein c-ets-1cardiacets-1miR-222nitric oxide synthasesexual dimorphism

Identifiers

PMID23632416
PMCPMC3680778
OpenAlexW1973367877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.